Loading...
•
Jun 30, 2022
Amphastar Q2 2022 Earnings Report
Reported net revenues of $123.5 million and GAAP net income of $17.3 million for the quarter ended June 30, 2022.
Key Takeaways
Amphastar Pharmaceuticals reported strong sales for the second quarter of 2022, with net revenues reaching $123.5 million and GAAP net income of $17.3 million, or $0.33 per share. Adjusted non-GAAP net income was $20.7 million, or $0.39 per share.
Net revenues for the second quarter were $123.5 million.
GAAP net income for the second quarter was $17.3 million, or $0.33 per share.
Adjusted non-GAAP net income for the second quarter was $20.7 million, or $0.39 per share.
Sales remained strong, allowing for increased investment in research and development.
Revenue by Segment
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...